DHR
Price
$190.09
Change
-$4.70 (-2.41%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
184.93B
4 days until earnings call
MTD
Price
$1196.83
Change
+$12.63 (+1.07%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
28.69B
13 days until earnings call
Interact to see
Advertisement

DHR vs MTD

Header iconDHR vs MTD Comparison
Open Charts DHR vs MTDBanner chart's image
Danaher
Price$190.09
Change-$4.70 (-2.41%)
Volume$17.86K
Capitalization184.93B
Mettler-Toledo International
Price$1196.83
Change+$12.63 (+1.07%)
VolumeN/A
Capitalization28.69B
DHR vs MTD Comparison Chart in %
Loading...
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DHR vs. MTD commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHR is a Hold and MTD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (DHR: $194.79 vs. MTD: $1205.68)
Brand notoriety: DHR and MTD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DHR: 84% vs. MTD: 70%
Market capitalization -- DHR: $184.93B vs. MTD: $28.69B
DHR [@Medical Specialties] is valued at $184.93B. MTD’s [@Medical Specialties] market capitalization is $28.69B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DHR’s FA Score shows that 1 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s).

  • DHR’s FA Score: 1 green, 4 red.
  • MTD’s FA Score: 1 green, 4 red.
According to our system of comparison, MTD is a better buy in the long-term than DHR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DHR’s TA Score shows that 4 TA indicator(s) are bullish while MTD’s TA Score has 4 bullish TA indicator(s).

  • DHR’s TA Score: 4 bullish, 4 bearish.
  • MTD’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, MTD is a better buy in the short-term than DHR.

Price Growth

DHR (@Medical Specialties) experienced а -5.22% price change this week, while MTD (@Medical Specialties) price change was -2.47% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.65%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was -2.13%.

Reported Earning Dates

DHR is expected to report earnings on Oct 28, 2025.

MTD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (-0.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DHR($185B) has a higher market cap than MTD($28.7B). DHR has higher P/E ratio than MTD: DHR (43.86) vs MTD (37.36). MTD YTD gains are higher at: -1.471 vs. DHR (-14.878). DHR has higher annual earnings (EBITDA): 7.5B vs. MTD (1.17B). DHR has more cash in the bank: 5.86B vs. MTD (69.8M). MTD has less debt than DHR: MTD (2.08B) vs DHR (19.5B). DHR has higher revenues than MTD: DHR (23.9B) vs MTD (3.79B).
DHRMTDDHR / MTD
Capitalization185B28.7B645%
EBITDA7.5B1.17B640%
Gain YTD-14.878-1.4711,011%
P/E Ratio43.8637.36117%
Revenue23.9B3.79B631%
Total Cash5.86B69.8M8,401%
Total Debt19.5B2.08B937%
FUNDAMENTALS RATINGS
DHR vs MTD: Fundamental Ratings
DHR
MTD
OUTLOOK RATING
1..100
1017
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
98
Overvalued
PROFIT vs RISK RATING
1..100
6960
SMR RATING
1..100
783
PRICE GROWTH RATING
1..100
6256
P/E GROWTH RATING
1..100
7277
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DHR's Valuation (30) in the Medical Specialties industry is significantly better than the same rating for MTD (98). This means that DHR’s stock grew significantly faster than MTD’s over the last 12 months.

MTD's Profit vs Risk Rating (60) in the Medical Specialties industry is in the same range as DHR (69). This means that MTD’s stock grew similarly to DHR’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is significantly better than the same rating for DHR (78). This means that MTD’s stock grew significantly faster than DHR’s over the last 12 months.

MTD's Price Growth Rating (56) in the Medical Specialties industry is in the same range as DHR (62). This means that MTD’s stock grew similarly to DHR’s over the last 12 months.

DHR's P/E Growth Rating (72) in the Medical Specialties industry is in the same range as MTD (77). This means that DHR’s stock grew similarly to MTD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DHRMTD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
61%
Momentum
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
61%
Declines
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 4 days ago
61%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
53%
Aroon
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
DHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPPP13.170.44
+3.46%
Sprott Physical Platinum and Palladium Trust
EGGS41.220.25
+0.62%
NestYield Total Return Guard ETF
MEXX16.650.03
+0.18%
Direxion Dly MSCI Mexico Bull 3X ShsETF
NUBD21.950.04
+0.18%
Nuveen ESG US Aggregate Bond ETF
UITB46.460.02
+0.04%
VictoryShares Core Intermediate Bond ETF